The latest trading session saw Hims & Hers Health, Inc. (HIMS) ending at $29.55, denoting a +1.41% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily gain ...

If your car needs a new transmission, you are in for a hefty repair bill. So, should you get a used transmission instead? Here's what you need to know.

The retailer's biggest savings bonanza since Prime Day is winding down, and we're huddled, tired, and begrudgingly impressed.

The venture offshoot of the hedge fund giant Maverick Capital has backed companies including Hims&Hers and MosaicML.

As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.

Hims & Hers (NYSE: HIMS) has seen incredibly high growth, but the market is skeptical that will continue. In this video, ...

The decision to trade Khris Middleton for Kyle Kuzma has been predictably disappointing.

Hims & Hers Health (NYSE:HIMS) has taken investors on a wild ride in 2025. The stock surged nearly 200% earlier this year, ...

Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, March 26 based on AAII’s Stock Grades.